Radioiodine treatment of differentiated thyroid carcinomas: residual ablation
Konrády, Aás.
Orvosi Hetilap 143(25): 1557; Author Reply
2002
ISSN/ISBN: 0030-6002 PMID: 12577410 Document Number: 550498
Document emailed within 1 workday
Related Documents
Bałdys-Waligórska, A.; Gołkowski, F.; Krzentowska-Korek, A.; Hubalewska-Dydejczyk, A. 2010: Radioiodine ablation of thyroid remnants in patients with differentiated thyroid carcinoma (DTC) following administration of rhTSH - a comparison with L-thyroxine withdrawal Endokrynologia Polska 61(5): 474-479Fu, H.; Ma, C.; Tang, L.; Wu, F.; Liu, B.; Wang, H. 2015: Recombinant human thyrotropin versus thyroid hormone withdrawal in radioiodine remnant ablation for differentiated thyroid cancer: a meta-analysis Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 59(1): 121-128
Saengsuda, Y. 2013: Radioiodine remnant ablation in low-risk differentiated thyroid cancer Journal of the Medical Association of Thailand 96(5): 614-624
Hasse-Lazar, K.; Handkiewicz-Junak, D.; Roskosz, Józef.; Szpak-Ulczok, S.; Krajewska, J.; Jurecka-Lubieniecka, B.; Jarzab, B. 2006: Recombinant human TSH stimulation in radioiodine treatment of disseminated differentiated thyroid cancer--update of current and our own experiences Endokrynologia Polska 57(4): 445-450
Thientunyakit, T.; Pusuwan, P.; Tuchinda, P.; Khiewvan, B.; Kiewvan, B. 2013: The correlation of post-operative radioiodine uptake and Tc-99m pertechnetate thyroid scintigraphy and the result of thyroid remnant ablation Journal of the Medical Association of Thailand 96(9): 1199-1207
Salvatori, M.; Rufini, V.; Garganese, M.C.; Di Giuda, D. 2000: Radioiodine therapy in differentiated thyroid carcinoma Rays 25(2): 221-238
Wiebe, V.; Erbe, W. 1973: Skeletal metastases from differentiated thyroid carcinomas. Radiographic appearances, scans, course during treatment Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 118(3): 313-319
Dietlein, M.; Dressler, J.; Farahati, J.; Leisner, B.; Moser, E.; Reiners, C.; Schicha, H.; Schober, O. 1999: Guidelines for radioiodine therapy (RIT) in differentiated thyroid cancer Nuklearmedizin. Nuclear Medicine 38(6a): 221-222
Marchesi, M.; Biffoni, M.; Tartaglia, F.; Lentini, A.; Nuccio, G.; Stocco, F.; Jaus, M.; Tromba, L.; Berni, A.; Sgueglia, M. 1995: Surgical treatment of differentiated thyroid carcinomas: results in 440 cases operated between 1970 and 1994 Annali Italiani di Chirurgia 66(6): 825-829
Hodak, S.P.; Carty, S.E. 2009: Radioiodine-resistant differentiated thyroid cancer: hope for the future Oncology 23(9): 775-776
Claimon, A.; Pusuwan, P.; Khiewvan, B. 2017: Factors Influencing the Success of the first Radioiodine Therapy for Differentiated Thyroid Carcinoma Journal of the Medical Association of Thailand 100(2): 207-218
Ronga, G.; Toteda, M.; D'Apollo, R.; De Cristofaro, F.; Filesi, M.; Acqualagna, G.; Argirò, R.; Ciancamerla, M.; Ugolini, F.; Montesano, T. 2012: Lymph node metastases from differentiated thyroid carcinoma: does radioiodine still play a role? La Clinica Terapeutica 163(5): 377-381
Markou, P.; Chatzopoulos, D. 2004: Isolation period prediction in patients with differentiated thyroid carcinoma treated after thyroidectomy by radioiodine-131 Hellenic Journal of Nuclear Medicine 7(3): 195-198
Sriprapaporn, J.; Sethanandha, C.; Yingsa-nga, T.; Komoltri, C.; Thongpraparn, T.; Harnnanthawiwai, C. 2015: Utility of Adding SPECT/CT Imaging to Post-Therapeutic Radioiodine Whole-Body Scan in Patients with Differentiated Thyroid Cancer Journal of the Medical Association of Thailand 98(6): 596-605
Russo, D.; Arturi, F.; Schlumberger, M.; Caillou, B.; Monier, R.; Filetti, S.; Suárez, H.G. 1995: Activating mutations of the TSH receptor in differentiated thyroid carcinomas Oncogene 11(9): 1907-1911
Fragu, P.; Nataf, B.M. 1977: Thyroid peroxidase activity in human differentiated carcinomas Annales de Radiologie 20(8): 728-730
Briele, B.; Hotze, A.; Kropp, J.; Bockisch, A.; Overbeck, B.; Grünwald, F.; Kaiser, W.; Biersack, H.J. 1991: A comparison of 201Tl and 99mTc-MIBi in the follow-up of differentiated thyroid carcinomas NUKLEARMEDIZIN. Nuclear Medicine 30(4): 115-124
Zakani, A.; Saghari, M.; Eftekhari, M.; Fard-Esfahani, A.; Fallahi, B.; Esmaili, J.; Assadi, M. 2011: Evaluation of radioiodine therapy in differentiated thyroid cancer subjects with elevated serum thyroglobulin and negative whole body scan using 131i with emphasize on the thallium scintigraphy in these subgroups European Review for Medical and Pharmacological Sciences 15(10): 1215-1221
Von Wasielewski, R.; Rhein, A.; Werner, M.; Scheumann, G.F.; Dralle, H.; Pötter, E.; Brabant, G.; Georgii, A. 1997: Immunohistochemical detection of E-cadherin in differentiated thyroid carcinomas correlates with clinical outcome Cancer Research 57(12): 2501-2507
Ahn, B-Cheol. 2013: Radioiodine SPET/CT guided needle aspiration as a useful technique for recurrence surveillance in a thyroidectomized differentiated thyroid cancer patient with negative US and serum Tg and positive Tg of the lymph node aspirate Hellenic Journal of Nuclear Medicine 16(2): 142-143